The Third European Cooperative Acute Stroke study demonstrated the effectiveness of intravenous (IV) thrombolysis with tissue plasminogen activator (tPA) in ischemic stroke treatment; the earlier the administration, the better the effect. This evidence concerns the gene PLAT and ischemic stroke.